TriLink BioTechnologies Company
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets.
Industry:
Gene Therapy
Technology:
Cancer
Headquarters:
San Diego, California, United States
Founded Date:
1996
Funding Status:
M&A
Estimated Revenue:
$10M to $50M